- Home
- ZDGE vs IMMX Comparison
ZDGE vs IMMX Comparison
Compare ZDGE & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- IMMX
- Stock Information
- Founded
- ZDGE 2008
- IMMX 2014
- Country
- ZDGE United States
- IMMX United States
- Employees
- ZDGE N/A
- IMMX N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- ZDGE Technology
- IMMX Health Care
- Exchange
- ZDGE Nasdaq
- IMMX Nasdaq
- Market Cap
- ZDGE 51.8M
- IMMX 51.1M
- IPO Year
- ZDGE N/A
- IMMX 2021
- Fundamental
- Price
- ZDGE $3.59
- IMMX $1.54
- Analyst Decision
- ZDGE
- IMMX Strong Buy
- Analyst Count
- ZDGE 0
- IMMX 1
- Target Price
- ZDGE N/A
- IMMX $7.00
- AVG Volume (30 Days)
- ZDGE 46.6K
- IMMX 143.4K
- Earning Date
- ZDGE 10-24-2024
- IMMX 11-11-2024
- Dividend Yield
- ZDGE N/A
- IMMX N/A
- EPS Growth
- ZDGE N/A
- IMMX N/A
- EPS
- ZDGE N/A
- IMMX N/A
- Revenue
- ZDGE $29,142,000.00
- IMMX N/A
- Revenue This Year
- ZDGE $13.67
- IMMX N/A
- Revenue Next Year
- ZDGE $13.41
- IMMX $200.00
- P/E Ratio
- ZDGE N/A
- IMMX N/A
- Revenue Growth
- ZDGE 4.15
- IMMX N/A
- 52 Week Low
- ZDGE $1.70
- IMMX $1.26
- 52 Week High
- ZDGE $5.18
- IMMX $7.75
- Technical
- Relative Strength Index (RSI)
- ZDGE 57.13
- IMMX 41.97
- Support Level
- ZDGE $3.55
- IMMX $1.26
- Resistance Level
- ZDGE $3.75
- IMMX $1.80
- Average True Range (ATR)
- ZDGE 0.19
- IMMX 0.16
- MACD
- ZDGE 0.03
- IMMX 0.00
- Stochastic Oscillator
- ZDGE 77.14
- IMMX 48.28
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.